-
2
-
-
33748944023
-
Hepatic resection for noncolorectal nonendocrine liver metastases. Analysis of 1425 patients and development of a prognostic model
-
Adam R, Chice L, Aloia T, Elias D, Salmon R, Rivoire M, et al. Hepatic resection for noncolorectal nonendocrine liver metastases. Analysis of 1425 patients and development of a prognostic model. Ann Surg. 2006;244:524-35.
-
(2006)
Ann Surg
, vol.244
, pp. 524-535
-
-
Adam, R.1
Chice, L.2
Aloia, T.3
Elias, D.4
Salmon, R.5
Rivoire, M.6
-
3
-
-
79953300698
-
The seed and soil hypothesis revisited: The role of tumor-stroma interactions in metastasis to different organs
-
Langley RR, Fidler IJ. The seed and soil hypothesis revisited: the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011;128:2527-35.
-
(2011)
Int J Cancer
, vol.128
, pp. 2527-2535
-
-
Langley, R.R.1
Fidler, I.J.2
-
4
-
-
49749097533
-
The number of metastatic lymph nodes is a significant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma
-
Kodera Y, Ito S, Mochizuki Y, Yamamura Y, Misawa K, Ohashi N, et al. The number of metastatic lymph nodes is a significant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma. World J Surg. 2008;32:2015-20.
-
(2008)
World J Surg
, vol.32
, pp. 2015-2020
-
-
Kodera, Y.1
Ito, S.2
Mochizuki, Y.3
Yamamura, Y.4
Misawa, K.5
Ohashi, N.6
-
5
-
-
79959373978
-
Japanese gastric cancer treatment guidelines
-
Japanese Gastric Cancer Association. ver. 3
-
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines (ver. 3). Gastric Cancer. 2010;2011(14):113-23.
-
(2010)
Gastric Cancer
, vol.2011
, Issue.14
, pp. 113-123
-
-
-
6
-
-
84865136371
-
Long-term outcomes after surgical resection for gastric cancer liver metastasis: An analysis of 64 macroscopically complete resections
-
Takemura N, Saiura A, Koga R, Arita J, Yoshioka R, Ono Y, et al. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg. 2012;397:951-7.
-
(2012)
Langenbecks Arch Surg
, vol.397
, pp. 951-957
-
-
Takemura, N.1
Saiura, A.2
Koga, R.3
Arita, J.4
Yoshioka, R.5
Ono, Y.6
-
7
-
-
10744232399
-
Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: A multi-institutional study of the indications for resection
-
Shirabe K, Shimada M, Matsumata T, Higashi H, Yakeishi Y, Wakiyama S, et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indication for resection. Hepatogastroenterology. 2003;50:1560-3. (Pubitemid 37186532)
-
(2003)
Hepato-Gastroenterology
, vol.50
, Issue.53
, pp. 1560-1563
-
-
Shirabe, K.1
Shimada, M.2
Matsumata, T.3
Higashi, H.4
Yakeishi, Y.5
Wakiyama, S.6
Ikeda, Y.7
Ezaki, T.8
Fukuzawa, S.9
Takenaka, K.10
Kishikawa, K.11
Ikeda, T.12
Taguchi, K.-I.13
Maehara, Y.14
Sugimachi, K.15
-
8
-
-
84867305932
-
Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases
-
Wang Y-N, Shen K-T, Ling J-Q, Gao X-D, Hou Y-Y, Wang X-F, et al. Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg. 2012;12:20.
-
(2012)
BMC Surg
, vol.12
, pp. 20
-
-
Wang, Y.-N.1
Shen, K.-T.2
Ling, J.-Q.3
Gao, X.-D.4
Hou, Y.-Y.5
Wang, X.-F.6
-
9
-
-
44849143053
-
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
-
DOI 10.1093/annonc/mdn026
-
Cheon SH, Rha SY, Jeung HC, Im CK, Kim SH, Kim HR, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol. 2008;19:1146-53. (Pubitemid 351796341)
-
(2008)
Annals of Oncology
, vol.19
, Issue.6
, pp. 1146-1153
-
-
Cheon, S.H.1
Rha, S.Y.2
Jeung, H.-C.3
Im, C.-K.4
Kim, S.H.5
Kim, H.R.6
Ahn, J.B.7
Roh, J.K.8
Noh, S.H.9
Chung, H.C.10
-
10
-
-
77955064227
-
Indication for hepatic resection in the treatment of liver metastasis from gastric cancer
-
Makino H, Kunisaki C, Izumisawa Y, Tokuhisa M, Oshima T, Nagano Y, et al. Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticancer Res. 2010;30:2367-76.
-
(2010)
Anticancer Res
, vol.30
, pp. 2367-2376
-
-
Makino, H.1
Kunisaki, C.2
Izumisawa, Y.3
Tokuhisa, M.4
Oshima, T.5
Nagano, Y.6
-
11
-
-
0035270727
-
Benefits and limits of hepatic resection for gastric metastases
-
DOI 10.1016/S0002-9610(01)00567-0, PII S0002961001005670
-
Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001;151:279-83. (Pubitemid 32480231)
-
(2001)
American Journal of Surgery
, vol.181
, Issue.3
, pp. 279-283
-
-
Ambiru, S.1
Miyazaki, M.2
Ito, H.3
Nakagawa, K.4
Shimizu, H.5
Yoshidome, H.6
Shimizu, Y.7
Nakajima, N.8
-
12
-
-
0036143942
-
Hepatic resection for metastatic tumors from gastric cancer
-
DOI 10.1097/00000658-200201000-00011
-
Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg. 2002;235:86-91. (Pubitemid 34062403)
-
(2002)
Annals of Surgery
, vol.235
, Issue.1
, pp. 86-91
-
-
Okano, K.1
Maeba, T.2
Ishimura, K.3
Karasawa, Y.4
Goda, F.5
Wakabayashi, H.6
Usuki, H.7
Maeta, H.8
-
13
-
-
0036717323
-
Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma
-
DOI 10.1016/S1091-255X(01)00075-0, PII S1091255X01000750
-
Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzl E, Muhlbacher F, et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg. 2002;6:682-9. (Pubitemid 40433486)
-
(2002)
Journal of Gastrointestinal Surgery
, vol.6
, Issue.5
, pp. 682-689
-
-
Zacherl, J.1
Zacherl, M.2
Scheuba, C.3
Steininger, R.4
Wenzl, E.5
Muhlbacher, F.6
Jakesz, R.7
Langle, F.8
-
14
-
-
34347374345
-
Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer
-
DOI 10.1002/jso.20739
-
Sakamoto Y, Sano T, Shimada K, Esaki M, Saka M, Fukagawa T, et al. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol. 2007;95:534-9. (Pubitemid 47177216)
-
(2007)
Journal of Surgical Oncology
, vol.95
, Issue.7
, pp. 534-539
-
-
Sakamoto, Y.1
Sano, T.2
Shimada, K.3
Esaki, M.4
Saka, M.5
Fukagawa, T.6
Katai, H.7
Kosuge, T.8
Sasako, M.9
-
15
-
-
58149384335
-
The role of hepatectomy for patients with liver metastases of gastric cancer
-
Morise Z, Sugiokla A, Hoshimoto S, Kato T, Ikeda M, Uyama I, et al. The role of hepatectomy for patients with liver metastases of gastric cancer. Hepatogastroenterology. 2008;55:1238-41.
-
(2008)
Hepatogastroenterology
, vol.55
, pp. 1238-1241
-
-
Morise, Z.1
Sugiokla, A.2
Hoshimoto, S.3
Kato, T.4
Ikeda, M.5
Uyama, I.6
-
16
-
-
54849412608
-
Liver resection for metastatic gastric cancer
-
Thelen A, Jonas S, Benckert C, Lopez-Hanninen E, Neumann U, Rudolph B, et al. Liver resection for metastatic gastric cancer. Eur J Surg Oncol. 2008;34:1328-34.
-
(2008)
Eur J Surg Oncol
, vol.34
, pp. 1328-1334
-
-
Thelen, A.1
Jonas, S.2
Benckert, C.3
Lopez-Hanninen, E.4
Neumann, U.5
Rudolph, B.6
-
17
-
-
77949652675
-
Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer
-
Tsujimoto H, Ichikura T, Ono S, Sugasawa H, Hiraki S, Sakamoto N, et al. Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int. 2010;4:406-13.
-
(2010)
Hepatol Int
, vol.4
, pp. 406-413
-
-
Tsujimoto, H.1
Ichikura, T.2
Ono, S.3
Sugasawa, H.4
Hiraki, S.5
Sakamoto, N.6
-
18
-
-
84856829410
-
Significance of surgical treatment of liver metastases from gastric cancer
-
Miki Y, Fujitani K, Hirao M, Kurokawa Y, Mano M, Tsujie M, et al. Significance of surgical treatment of liver metastases from gastric cancer. Anticancer Res. 2012;32:665-70.
-
(2012)
Anticancer Res
, vol.32
, pp. 665-670
-
-
Miki, Y.1
Fujitani, K.2
Hirao, M.3
Kurokawa, Y.4
Mano, M.5
Tsujie, M.6
-
19
-
-
84856853759
-
Surgical treatment of liver metastases of gastric cancer: Is local treatment in a systemic disease worthwhile?
-
Oxf
-
Garancini M, Uggeri F, Degrate L, Nespoli L, Gianotti L, Nespoli A, et al. Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB (Oxf). 2012;14:209-15.
-
(2012)
HPB
, vol.14
, pp. 209-215
-
-
Garancini, M.1
Uggeri, F.2
Degrate, L.3
Nespoli, L.4
Gianotti, L.5
Nespoli, A.6
-
20
-
-
84863718863
-
Outcome of operative therapy of hepatic metastatic stomach carcinoma: A retrospective analysis
-
Schildberg CW, Croner R, Merkel S, Schellerer V, Muller V, Yedibela S, et al. Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis. World J Surg. 2012;36:872-8.
-
(2012)
World J Surg
, vol.36
, pp. 872-878
-
-
Schildberg, C.W.1
Croner, R.2
Merkel, S.3
Schellerer, V.4
Muller, V.5
Yedibela, S.6
-
21
-
-
0035178132
-
A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma
-
DOI 10.1016/S0002-9270(01)03840-0, PII S0002927001038400
-
Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A, Kobayashi A, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol. 2001;96:3178-84. (Pubitemid 33103756)
-
(2001)
American Journal of Gastroenterology
, vol.96
, Issue.11
, pp. 3178-3184
-
-
Imamura, H.1
Matsuyama, Y.2
Shimada, R.3
Kubota, M.4
Nakayama, A.5
Kobayashi, A.6
Kitamura, H.7
Ikegami, T.8
Miyagawa, S.-I.9
Kawasaki, S.10
-
22
-
-
59349121849
-
Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?
-
Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwarz ME, Labow DM. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol. 2009;16:379-84.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 379-384
-
-
Sarpel, U.1
Bonavia, A.S.2
Grucela, A.3
Roayaie, S.4
Schwarz, M.E.5
Labow, D.M.6
-
23
-
-
77951992922
-
Gastric cancer
-
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, et al. Gastric cancer. J Natl Compr Canc Netw. 2010;8:378-409.
-
(2010)
J Natl Compr Canc Netw
, vol.8
, pp. 378-409
-
-
Ajani, J.A.1
Barthel, J.S.2
Bekaii-Saab, T.3
Bentrem, D.J.4
D'Amico, T.A.5
Das, P.6
-
24
-
-
79952328656
-
Imaging in assessing hepatic and peritoneal metastases of gastric cancer: A systemic review
-
Wang Z, Chen J-Q. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systemic review. BMC Gastroenterol. 2011;11:19.
-
(2011)
BMC Gastroenterol
, vol.11
, pp. 19
-
-
Wang, Z.1
Chen, J.-Q.2
-
25
-
-
80052587317
-
What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis
-
Maas M, Rutten IJG, Nelemans PJ, Lambregts DM, Cappendijk VC, Beets GL, et al. What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1560-71.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 1560-1571
-
-
Maas, M.1
Rutten, I.J.G.2
Nelemans, P.J.3
Lambregts, D.M.4
Cappendijk, V.C.5
Beets, G.L.6
-
26
-
-
81755171104
-
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer
-
Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387-93.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4387-4393
-
-
Sasako, M.1
Sakuramoto, S.2
Katai, H.3
Kinoshita, T.4
Furukawa, H.5
Yamaguchi, T.6
-
27
-
-
84856382467
-
Adjuvant vapecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): A phase 3 open-label, randomised controlled trial
-
Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant vapecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315-21.
-
(2012)
Lancet
, vol.379
, pp. 315-321
-
-
Bang, Y.J.1
Kim, Y.W.2
Yang, H.K.3
Chung, H.C.4
Park, Y.K.5
Lee, K.H.6
-
28
-
-
33745726677
-
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
-
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
-
(2006)
N Engl J Med
, vol.355
, pp. 11-20
-
-
Cunningham, D.1
Allum, W.H.2
Stenning, S.P.3
Thompson, J.N.4
Van De Velde, C.J.5
Nicolson, M.6
-
29
-
-
79551693463
-
Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer with synchronous multiple hepatic metastasis: A pilot study
-
Li Z-Y, Tang L, Zhang L-H, Bu Z-D, Wu A-W, Wu X-J, et al. Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer with synchronous multiple hepatic metastasis: a pilot study. Med Oncol. 2010;27:1314-8.
-
(2010)
Med Oncol
, vol.27
, pp. 1314-1318
-
-
Li, Z.-Y.1
Tang, L.2
Zhang, L.-H.3
Bu, Z.-D.4
Wu, A.-W.5
Wu, X.-J.6
-
30
-
-
77956262693
-
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
-
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687-97.
-
(2010)
Lancet
, vol.376
, pp. 687-697
-
-
Bang, Y.J.1
Van Cutsem, E.2
Feyereislova, A.3
Chung, H.C.4
Shen, L.5
Sawaki, A.6
-
31
-
-
40749153540
-
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial
-
Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215-21.
-
(2008)
Lancet Oncol
, vol.9
, pp. 215-221
-
-
Koizumi, W.1
Narahara, H.2
Hara, T.3
Takagane, A.4
Akiya, T.5
Takagi, M.6
-
32
-
-
38049047178
-
Capecitabine and oxaliplatin for advanced esophagogastric cancer
-
Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358:36-46.
-
(2008)
N Engl J Med
, vol.358
, pp. 36-46
-
-
Cunningham, D.1
Starling, N.2
Rao, S.3
Iveson, T.4
Nicolson, M.5
Coxon, F.6
-
33
-
-
80053573446
-
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A randomized, doubleblind, placebo-controlled phase III study
-
Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, Park SR, et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, doubleblind, placebo-controlled phase III study. J Clin Oncol. 2011;29:3968-76.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3968-3976
-
-
Ohtsu, A.1
Shah, M.A.2
Van Cutsem, E.3
Rha, S.Y.4
Sawaki, A.5
Park, S.R.6
-
34
-
-
79953025190
-
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
-
Narahara H, Ishii H, Imamura H, Tsuburaya A, Chin K, Imamoto H, et al. Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002). Gastric Cancer. 2011;14:72-80.
-
(2011)
Gastric Cancer
, vol.14
, pp. 72-80
-
-
Narahara, H.1
Ishii, H.2
Imamura, H.3
Tsuburaya, A.4
Chin, K.5
Imamoto, H.6
-
35
-
-
16644368878
-
Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study
-
DOI 10.1093/jjco/hyh120
-
Yoshida M, Ohtsu A, Boku N, Miyata Y, Shirao K, Shimada Y, et al. Longterm survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Jpn J Clin Oncol. 2004;34:654-9. (Pubitemid 41615277)
-
(2004)
Japanese Journal of Clinical Oncology
, vol.34
, Issue.11
, pp. 654-659
-
-
Yoshida, M.1
Ohtsu, A.2
Boku, N.3
Miyata, Y.4
Shirao, K.5
Shimada, Y.6
Hyodo, I.7
Koizumi, W.8
Kurihara, M.9
Yoshida, S.10
Yamamoto, S.11
-
36
-
-
0032861226
-
Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer
-
DOI 10.1159/000012034
-
Kumada T, Arai Y, Itoh K, Takayasu Y, Nakamura K, Ariyoshi Y, et al. Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer. Oncology. 1999;57:216-23. (Pubitemid 29481695)
-
(1999)
Oncology
, vol.57
, Issue.3
, pp. 216-223
-
-
Kumada, T.1
Arai, Y.2
Itoh, K.3
Takayasu, Y.4
Nakamura, K.5
Ariyoshi, Y.6
Tajima, K.7
-
37
-
-
34547489630
-
Treatment of multiple liver metastasis from gastric carcinoma
-
Ojima H, Ootake S, Yokobori T, Mochida Y, Hosouchi Y, Nishida Y, et al. Treatment of multiple liver metastasis from gastric carcinoma. World J Surg Oncol. 2007;5:70.
-
(2007)
World J Surg Oncol
, vol.5
, pp. 70
-
-
Ojima, H.1
Ootake, S.2
Yokobori, T.3
Mochida, Y.4
Hosouchi, Y.5
Nishida, Y.6
-
38
-
-
0034865115
-
Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy
-
Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T. Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. J Vasc Interv Radiol. 2001;12:957-63. (Pubitemid 32756866)
-
(2001)
Journal of Vascular and Interventional Radiology
, vol.12
, Issue.8
, pp. 957-963
-
-
Inaba, Y.1
Arai, Y.2
Matsueda, K.3
Takeuchi, Y.4
Aramaki, T.5
-
39
-
-
77952471110
-
Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma
-
Kim HR, Cheon SH, Lee KH, Ahn JR, Jeung HC, Lee SS, et al. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma. Int J Hypertherm. 2010;26:305-13.
-
(2010)
Int J Hypertherm
, vol.26
, pp. 305-313
-
-
Kim, H.R.1
Cheon, S.H.2
Lee, K.H.3
Ahn, J.R.4
Jeung, H.C.5
Lee, S.S.6
-
41
-
-
33744765541
-
Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer
-
DOI 10.1097/01.RVI.0000188738.84911.3B, PII 0000251820051200000028
-
Yamakado K, Nakatsuka A, Takaki H, Mori Y, Tonouchi H, Kusunoki M, et al. Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol. 2005;16:1747-51. (Pubitemid 44431175)
-
(2005)
Journal of Vascular and Interventional Radiology
, vol.16
, Issue.12
, pp. 1747-1751
-
-
Yamakado, K.1
Nakatsuka, A.2
Takaki, H.3
Mori, Y.4
Tonouchi, H.5
Kusunoki, M.6
Kida, H.7
Takeda, K.8
-
42
-
-
84866687176
-
Radiofrequency ablation versus resection for colorectal cancer liver metastases: A meta-analysis
-
Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7:e45493.
-
(2012)
PLoS One
, vol.7
-
-
Weng, M.1
Zhang, Y.2
Zhou, D.3
Yang, Y.4
Tang, Z.5
Zhao, M.6
|